Clinical Trial: A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity

U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07310563) titled 'A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity' on Dec. 16.

Brief Summary: The primary objective of this trial is to evaluate the pharmacokinetics (PK) of AMG 133 administered alone and in combination with an antiemetic medication, ondansetron, in participants living with overweight or obesity.

Study Start Date: Dec. 10, 2024

Study Type: INTERVENTIONAL

Condition: Overweight Obesity

Intervention: DRUG: AMG 133

AMG 133 will be administered SC.

DRUG: Ondansetron

Ondansetron will be administered via ODT.

Recruitment Status: COMPLETED

Sponsor: Amgen...